Ifp Advisors, Inc Zynerba Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$0.3 - $0.43 $6 - $9	23 New	23 $0
Q3 2021 Oct 06, 2021	SELL	$3.72 - $5.35 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$3.83 - $5.98 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$3.33 - $8.76 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	SELL	$7.56 - $15.44 $3,780 - $7,720	-500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.6 - $6.22 $216 - $373	60 Added 13.64%	500 $3,000
Q2 2018 Aug 07, 2018	SELL	$7.98 - $12.39 $1,197 - $1,858	-150 Reduced 25.42%	440 $0
Q1 2018 Jun 03, 2019	BUY	$8.49 - $13.46 $1,273 - $2,019	150 Added 34.09%	590 $7,000
Q1 2018 May 09, 2018	SELL	$8.49 - $13.46 $1,273 - $2,019	-150 Reduced 25.42%	440 $0
Q4 2017 Jan 24, 2018	SELL	$8.69 - $14.59 $869 - $1,459	-100 Reduced 14.49%	590 $0
Q3 2017 Oct 30, 2017	SELL	$5.73 - $9.44 $2,377 - $3,917	-415 Reduced 37.56%	690 $6,000
Q2 2017 Jun 03, 2019	BUY	N/A	565 Added 104.63%	1,105 $19,000
Q1 2017 Jun 03, 2019	SELL	N/A	-3,360 Reduced 86.15%	540 $11,000
Q4 2016 Jun 03, 2019	BUY	N/A	3,300 Added 550.0%	3,900 $61,000
Q2 2016 Jun 03, 2019	BUY	N/A	100 Added 20.0%	600 $4,000
Q1 2016 Jun 03, 2019	BUY	N/A	500	500 $3,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.